Health 15 September 2026 Daily Monitor (Uganda)
Honoring King Oyo: A Call for a Cancer Institute in Fort Portal
Following the tragic passing of King Oyo Rukidi IV, there's a growing sentiment to establish a dedicated cancer institute in Fort Portal, a fitting tribute to his impactful reign and a crucial step in addressing health challenges in the region. Source: https://www.monitor.co.ug/uganda/oped/commentary/let-s-have-a-king-oyo-rukidi-iv-cancer-institute-fort-portal-5595454
The recent passing of His Majesty Oyo Nyimba Kabamba Iguru Rukidi IV has left a profound void in the Tooro Kingdom and Uganda. His Majesty’s 31-year reign, which began remarkably in his childhood, evolved into a period of significant leadership and transformation.
Beyond his status as the world’s youngest monarch, King Oyo was recognized by those close to him as a pragmatic reformer. He understood that the strength of a cultural institution is intrinsically linked to the well-being of its people, encompassing their health, environmental security, and economic stability.
In the wake of this immense loss, a compelling proposal has emerged: the establishment of a King Oyo Rukidi IV Cancer Institute in Fort Portal. Such an institution would serve as a lasting memorial to his vision and a vital resource for cancer treatment and research in the region.
Cancer continues to be a significant health burden, particularly in resource-limited settings. A dedicated cancer center in Fort Portal would not only provide much-needed medical services to the people of Tooro and surrounding areas but also foster advancements in understanding and combating the disease. This would be a tangible way to ensure that his legacy continues to benefit the health and lives of Ugandans for generations to come.
The proposed institute represents a forward-thinking approach to honoring a monarch who cared deeply for his subjects. It aligns with his understanding that true leadership involves addressing the fundamental needs of the community, including access to quality healthcare.